Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

被引：18

作者：

Cuschieri, K. ^{[1
]}

Brewster, D. H. ^{[2
]}

Williams, A. R. W. ^{[3
]}

Millan, D. ^{[4
]}

Murray, G. ^{[5
]}

Nicoll, S. ^{[6
]}

Imrie, J. ^{[7
]}

Hardie, A. ^{[1
]}

Graham, C. ^{[8
]}

Cubie, H. A. ^{[1
]}

机构：

[1] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Scottish HPV Reference Lab, Edinburgh EH16 4SA, Midlothian, Scotland

[2] NHS Natl Serv Scotland, Informat Serv Div, Scottish Canc Registry, Edinburgh EH12 9EB, Midlothian, Scotland

[3] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh EH16 4SA, Midlothian, Scotland

[4] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland

[5] Aberdeen Royal Infirm, Dept Pathol, Aberdeen AB25 2ZN, Scotland

[6] Ninewells Hosp, Dept Pathol, Dundee DD1 9SY, Scotland

[7] Monklands Gen Hosp, Dept Cytopathol, Airdrie ML6 OJS, Scotland

[8] Wellcome Trust Clin Res Facil, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

BRITISH JOURNAL OF CANCER | 2010年 / 102卷 / 05期

关键词：

HPV; genotyping; Scotland; LESIONS;

D O I：

10.1038/sj.bjc.6605556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BACKGROUND/METHODS: This study evaluated human papillomavirus (HPV) type prevalence in 370 Scottish invasive cervical cancers (ICCs) using HPV genotyping and HPV mRNA detection. RESULTS: HPV 16 and/or 18 was detected in 72% of cancers overall and in 82% of HPV-positive cancers. HPV 45 and 16 were the most frequently transcribed types. CONCLUSION: A significant reduction in ICC in Scotland should be achieved through the HPV immunisation programme. British Journal of Cancer (2010) 102, 930-932. doi: 10.1038/sj.bjc.6605556 www.bjcancer.com Published online 9 February 2010 (C) 2010 Cancer Research UK

引用

页码：930 / 932

页数：3

共 50 条

[31] HPV vaccines: The opportunity to prevent multiple cancers
Giuliano, Anna R.
CANCER RESEARCH, 2012, 72
[32] Awareness and knowledge of HPV, HPV-related cancers, and HPV vaccines in a working, uninsured clinic population
Reitkopf, Carmen Radecki B.
Rutten, Lila Finney
Jacobson, Debra
Wilson, Patrick
Albertie, Monica
Jacobson, Robert M.
Colon-Otero, Gerardo
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
[33] Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications
Ermel, Aaron
Qadadri, Brahim
Tong, Yan
Orang'o, Omenge
Macharia, Benson
Ramogola-Masire, Doreen
Zetola, Nicola M.
Brown, Darron R.
INFECTIOUS AGENTS AND CANCER, 2016, 11 : 1 - 9
[34] Distinctive distribution of HPV genotypes in cervical cancers in multi-ethnic Suriname: implications for prevention and vaccination
Grunberg, M. G.
Chan, M.
Adhin, M. R.
EPIDEMIOLOGY AND INFECTION, 2017, 145 (02): : 245 - 253
[35] Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications
Aaron Ermel
Brahim Qadadri
Yan Tong
Omenge Orang’o
Benson Macharia
Doreen Ramogola-Masire
Nicola M. Zetola
Darron R. Brown
Infectious Agents and Cancer, 11
[36] Signaling pathways in HPV-associated cancers and therapeutic implications
Chen, Jiezhong
REVIEWS IN MEDICAL VIROLOGY, 2015, 25 : 24 - 53
[37] HPV-associated cancers
Minichsdorfer, Christoph
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (04) : 352 - 356
[38] HPV-associated cancers
Christoph Minichsdorfer
memo - Magazine of European Medical Oncology, 2019, 12 : 352 - 356
[39] HPV types present in invasive cervical cancers of HIV-seropositive women
Strickler, Howard D.
Palefsky, Joel M.
Burk, Robert D.
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1224 - 1225
[40] Therapeutic Vaccines for HPV-Associated Cervical Malignancies: A Systematic Review
Alouini, Souhail
Pichon, Chantal
VACCINES, 2024, 12 (04)

← 1 2 3 4 5 →